Pegylated Asparaginase‐Induced Liver Injury: A Case‐Based Review and Data From Pharmacovigilance-Reference-Cited by-同舟云学术

Pegylated Asparaginase‐Induced Liver Injury: A Case‐Based Review and Data From Pharmacovigilance

Published:2022-04-14 Issue:9 Volume:62 Page:1142-1150
ISSN:0091-2700
Container-title:The Journal of Clinical Pharmacology
language:en
Short-container-title:The Journal of Clinical Pharma

Author:

Vetro Calogero¹^ORCID,Duminuco Andrea²,Gozzo Lucia³,Maugeri Cinzia¹,Parisi Marina¹,Brancati Serena³,Longo Laura³,Vitale Daniela Cristina³,Romano Giovanni Luca⁴,Ciuni Roberto⁵,Mauro Elisa¹,Fiumara Paolo Fabio¹,Palumbo Giuseppe Alberto Maria¹²⁶,Drago Filippo³⁷,Di Raimondo Francesco¹⁵

Affiliation:

1. Haematology Unit Azienda Ospedaliero Universitaria Policlinico “G. Rodolico – S. Marco” Catania Italy

2. Postgraduate School of Hematology University of Catania Catania Italy

3. Clinical Pharmacology Unit/Regional Pharmacovigilance Centre Azienda Ospedaliero Universitaria Policlinico “G. Rodolico – S. Marco” Catania Italy

4. Department of Biomedical and Biotechnological Sciences University of Catania Catania Italy

5. Department of Chirurgia Generale e Specialità Medico‐Chirurgiche University of Catania Catania Italy

6. Department of Scienze Mediche Chirurgiche e Tecnologie Avanzate “G.F. Ingrassia” University of Catania Catania Italy

7. Centre for Research and Consultancy in HTA and Drug Regulatory Affairs (CERD), University of Catania Catania Italy

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/jcph.2052

Reference69 articles.

1. SwerdlowSH CampoE HarrisNL et al.WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues.France:Lyon;2008.

2. STUDIES ON THE MECHANISM OF TUMOR INHIBITION BY L-ASPARAGINASE

3. Incidence and management of asparaginase‐associated adverse events in patients with acute lymphoblastic leukemia;Earl M;Clin Adv Hematol Oncol,2009

4. Is asparaginase a critical component in the treatment of acute lymphoblastic leukemia?

5. A pediatric regimen for older adolescents and young adults with acute lymphoblastic leukemia: results of CALGB 10403

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Early Access for Medicines in ITALY: The Case of Ruxolitinib for Patients with Graft-Versus-Host Disease;Journal of Clinical Medicine;2024-07-22

2. Severe Gastrointestinal Toxicity Following the Use of Gilteritinib: A Case Series and Analysis of Postmarketing Surveillance Data;Healthcare;2023-05-18

3. Multiple drugs;Reactions Weekly;2023-02-04